SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.04.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 15.04.09 | Novartis hold | Deutsche Bank AG | |
| 14.04.09 | Novartis buy | UBS AG | |
| 09.04.09 | Basilea Pharmaceutica | Fuchsbriefe | |
| 09.04.09 | Lonza kaufen | Fuchsbriefe | |
| 09.04.09 | Novartis kaufen | Fuchsbriefe | |
| 09.04.09 | Lonza | Focus Money | |
| 06.04.09 | Novartis buy | Citigroup Corp. | |
| 19.03.09 | Novartis buy | Goldman Sachs Group Inc. | |
| 17.03.09 | Novartis neutral | Credit Suisse Group | |
| 25.02.09 | Novartis neutral | Credit Suisse Group | |
| 23.02.09 | Novartis market perform | Wachovia Securities, LLC | |
| 12.02.09 | Novartis buy | Jefferies & Company Inc. | |
| 12.02.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 11.02.09 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 11.02.09 | Novartis buy | Citigroup Corp. | |
| 10.02.09 | Novartis halten | Raiffeisen Centrobank AG | |
| 29.01.09 | Novartis buy | UBS AG | |
| 30.01.09 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 02.02.09 | Novartis kaufen | National-Bank AG | |
| 29.01.09 | Novartis kaufen | Independent Research GmbH | |
| 29.01.09 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 28.01.09 | Novartis hold | Société Générale Group S.A. (SG) | |
| 27.01.09 | Novartis | Volksbank Karlsruhe eG | |
| 26.01.09 | Novartis hold | Société Générale Group S.A. (SG) | |
| 27.01.09 | Novartis hold | Jefferies & Company Inc. | |
| 22.01.09 | Kuros (Kuros Biosciences) | Focus Money | |
| 14.01.09 | Kuros (Kuros Biosciences) | Global Biotech Investing | |
| 15.12.08 | Novartis neutral | JP Morgan Chase & Co. | |
| 15.12.08 | Novartis buy | UBS AG | |
| 11.12.08 | Sonova | Focus Money | |
| 11.12.08 | Kuros (Kuros Biosciences) | Focus Money | |
| 04.12.08 | Novartis hold | Société Générale Group S.A. (SG) | |
| 02.12.08 | Novartis outperform | Wachovia Securities, LLC | |
| 27.11.08 | Straumann neutral | JP Morgan Chase & Co. | |
| 26.11.08 | Sonova | Zürcher Kantonalbank AG | |
| 25.11.08 | Novartis overweight | Morgan Stanley | |
| 21.11.08 | Novartis buy | Goldman Sachs Group Inc. | |
| 20.11.08 | Novartis neutral | JP Morgan Chase & Co. | |
| 21.11.08 | Novartis buy | UBS AG |